||Recombinant human SNX5 ( 404 aa ) fused with T7 tag at N-terminal was expressed in E. coli.
||1.0 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, arginine, DTT and Glycerol.
||MASMTGGQQMGRGEFMAAVPELLQQQEEDRSKLRSVSVDLNVDPSLQIDIPDALSERDKVKFTVHTKTTLPTFQS PEFSVTRQHEDFVWLHDTLIETTDYAGLIIPPAPTKPDFDGPREKMQKLGEGEGSMTKEEFAKMKQELEAEYLAV FKKTVSSHEVFLQRLSSHPVLSKDRNFHVFLEYDQDLSVRRKNTKEMFGGFFKSVVKSADEVLFTGVKEVDDFFE QEKNFLINYYNRIKDSCVKADKMTRSHKNVADDYIHTAACLHSLALEEPTVIKKYLLKVAELFEKLRKVEGRVSS DEDLKLTELLRYYMLNIEAAKDLLYRRTKALIDYENSNKALDKARLKSKDVKLAEAHQQECCQKFEQLSESAKEE LINFKRKRVAAFRKNLIEMSELEIKHARNNVSLLQSCIDLFKNN
||>90% by SDS-PAGE
||1. May be used for in vitro SNX5 mediated cell receptor internalization regulation study by intracellular delivery of this protein with "ProFectin" reagent.2. May be used for mapping SNX5 protein – protein interaction assay.3. May be used as specific substrate protein for kinase and ubiquitin (Sumo pathway) related enzyme functional screening assays.4. Potential biomarker protein for papillary thyroid carcinoma diagnosis.5. May be used for specific antibody production.
||Keep at -80°C for long term storage. Product is stable at 4 °C for at least 30 days.